The company stated that the observations primarily pertain to procedural improvements and are not related to data integrity. Shares of Piramal Pharma Ltd ended at ₹196.70, down by ₹3.15, or 1.58%, on the BSE.
The company stated that the observations primarily pertain to procedural improvements and are not related to data integrity. Shares of Piramal Pharma Ltd ended at ₹196.70, down by ₹3.15, or 1.58%, on the BSE.